Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a type of blood cancer called classic Hodgkin's lymphoma, where a specific laboratory marker called PAX5 has come back negative
- People where doctors are uncertain whether the diagnosis is classic Hodgkin's lymphoma (with an unusual PAX5-negative result) or a different blood cancer called ALK-negative anaplastic large T-cell lymphoma (also PAX5 negative)
- Adults (male or female) at the time of their diagnosis
- People for whom genetic and/or chromosome test results from their cancer are available
Who may not be able to join:
- People whose diagnosis is something other than the specific conditions being studied in this trial, or for whom clinical, tissue, or genetic information about their cancer is not available
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +390512144562
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Atypical Hodgkin Lymphoma
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.